MediWound: Funding, Investors & Team (Sep 2026)
MediWound is a biotechnology niche specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™. NexoBrid™ successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
MediWound has raised $59.2M across 3 funding rounds on record, the most recent an undisclosed round of $27.5M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MediWound Company Profile and Key Stats
Latest funding round on record: Feb 2023.
MediWound Funding Rounds
MediWound raised $1.7M in a Grant announced in Feb 2022.
7 months later, a Post-IPO Equity of $30.0M was announced in Sep 2022.
5 months later, an undisclosed round of $27.5M was announced in Feb 2023.
MediWound Founders and Leadership Team
Contact details for the MediWound team: 1 of 2 have an email address on file.
Start 14-day free trial →MediWound Funding Compared to Other Biotechnology Startups
MediWound's latest round of $27.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MediWound in Biotechnology and Yavne
Companies Similar to MediWound
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
MediWound Funding FAQs
What does MediWound do?
MediWound is a biotechnology niche specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™. NexoBrid™ successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
How much funding has MediWound raised?
MediWound has raised $59.2M across 3 rounds on record. The most recent is an undisclosed round of $27.5M announced in Feb 2023.
When did MediWound last raise funding?
MediWound's most recent funding round on record is an undisclosed round of $27.5M, announced in Feb 2023.
Who founded MediWound?
FundedIQ lists Lior Rosenberg (Founder) at MediWound.
Who is the CEO of MediWound?
Gal Cohen is listed as CEO at MediWound.
Where is MediWound headquartered?
MediWound is based in Yavne, Hamerkaz, Israel.
How many employees does MediWound have?
MediWound is in the 51-100 employee band.
How does MediWound's funding compare to other Biotechnology startups?
MediWound's latest round of $27.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's MediWound Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MediWound is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.